Ignite Creation Date:
2024-05-05 @ 4:50 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00323011
Status:
TERMINATED
Last Update Posted:
2014-05-21
First Post:
2006-05-05
Brief Title:
FOLFIRI Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal Cancer
Sponsor:
University of Southern California
Organization:
University of Southern California
Organization Data
Organization:
University of Southern California
Class:
OTHER
Study ID:
3C-05-2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Southern California
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Syma Iqbal MD
Old Organization:
University of Southern California
Collaborators
| Name | Class |
|---|---|
| Pfizer | INDUSTRY |